Thérèse Gargi

472 total citations
14 papers, 218 citations indexed

About

Thérèse Gargi is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Thérèse Gargi has authored 14 papers receiving a total of 218 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 6 papers in Genetics and 5 papers in Oncology. Recurrent topics in Thérèse Gargi's work include Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (3 papers). Thérèse Gargi is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Viral-associated cancers and disorders (3 papers). Thérèse Gargi collaborates with scholars based in France, United Kingdom and United States. Thérèse Gargi's co-authors include David Pérol, Olivier Trédan, Sylvie Chabaud, Pierre Biron, Catherine Sebban, Thomas Bachelot, Anne Meunier, Jean‐Paul Guastalla, Patrick Bachmann and Pascale Roux and has published in prestigious journals such as Blood, Oncogene and Neural Networks.

In The Last Decade

Thérèse Gargi

14 papers receiving 211 citations

Peers

Countries citing papers authored by Thérèse Gargi

Since Specialization

Citations

This map shows the geographic impact of Thérèse Gargi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thérèse Gargi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thérèse Gargi more than expected).

Fields of papers citing papers by Thérèse Gargi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thérèse Gargi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thérèse Gargi. The network helps show where Thérèse Gargi may publish in the future.

Co-authorship network of co-authors of Thérèse Gargi

This figure shows the co-authorship network connecting the top 25 collaborators of Thérèse Gargi. A scholar is included among the top collaborators of Thérèse Gargi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thérèse Gargi. Thérèse Gargi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Event-Free Survival at 12 Months (EFS12) from Diagnosis Is a Robust Endpoint for Disease-Related Survival in Patients with Follicular Lymphoma in the Immunochemotherapy Era 2014 ·Blood ·Matthew J. Maurer, Hervé Ghesquières, Stephen M. Ansell, Carrie A. Thompson, Grzegorz S. Nowakowski, David J. Inwards, Cristine Allmer, Emmanuelle Nicolas‐Virelizier, Catherine Sebban, Pierre Biron, Catherine Chassagne‐Clément, Thérèse Gargi, William R. Macon, Andrew L. Feldman, Sergei Syrbu, Susan L. Slager, Thomas E. Witzig, Thomas M. Habermann, Brian K. Link, James R. Cerhan	8
2	Impact of the introduction of rituximab in first‐line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long‐term follow‐up 2014 ·Hematological Oncology ·Emmanuelle Nicolas‐Virelizier, Céline Ségura‐Ferlay, Hervé Ghesquières, Catherine Chassagne‐Clément, Thérèse Gargi, Pierre Biron, Amine Belhabri, (unknown), (unknown), Sylvie Chabaud, Catherine Sebban	3
3	Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy Who Are Alive and Progression Free 12 Months After Diagnosis Have a Subsequent Overall Survival Similar to That of the General Population 2012 ·Blood ·Matthew J. Maurer, Hervé Ghesquières, Thomas E. Witzig, Carrie A. Thompson, Ivana N. Micallef, William R. Macon, Sergei Syrbu, Paul J. Kurtin, Cristine Allmer, Thérèse Gargi, Emmanuelle Nicolas‐Virelizier, Catherine Sebban, Susan L. Slager, Thomas M. Habermann, Brian K. Link, James R. Cerhan	4
4	Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis 2011 ·Oncogene ·(unknown), Béatrice Duthey, Vanja Sisirak, Danièle Salaün, Thérèse Gargi, Olivier Trédan, Pascal Finetti, François Bertucci, Daniel Birnbaum, Nathalie Bendriss‐Vermare, Ali Badache	34
5	Prognostic Value of 18F-FDG Positron Emission Tomography Used for Assessment of the First Line Therapy in 410 Diffuse Large B-Cell Lymphoma Patients: A Daily Practice Evaluation Before and After the Prescription of This Metabolic Imaging Technique, 2011 ·Blood ·Hervé Ghesquières, Céline Ferlay, Emilie Lavergne, (unknown), (unknown), (unknown), Thérèse Gargi, Sylvie Chabaud, Catherine Chassagne‐Clément, Bertrand Favier, Pierre Biron, Thomas Mognetti, (unknown), Catherine Sebban, Jean‐Yves Blay, (unknown)	1
6	Evaluation in the Context of Daily Practice of Follicular Lymphoma patients' Outcome Before and After Approval of Rituximab in First Line Therapy in This Indication: Results of a Retrospective Analysis of 247 Unselected Patients with a 5-Year Median of Follow-up, 2011 ·Blood ·(unknown), Céline Ségura‐Ferlay, (unknown), (unknown), Thérèse Gargi, Catherine Chassagne‐Clément, Bertrand Favier, Pierre Biron, Amine Belhabri, Catherine Sebban, Jean‐Yves Blay, Hervé Ghesquières	2
7	Comparison of Artificial Neural Network with Logistic Regression as Classification Models for Variable Selection for Prediction of Breast Cancer Patient Outcomes 2010 ·HAL (Le Centre pour la Communication Scientifique Directe) ·Valérie Bourdès, (unknown), (unknown), (unknown), David Pérol, Sylvie Chabaud, Thomas Bachelot, Thérèse Gargi, Sylvie Négrier	21
8	Body weight change in women receiving adjuvant chemotherapy for breast cancer: A French prospective study 2009 ·Clinical Nutrition ·Olivier Trédan, Agathe Bajard, Anne Meunier, Pascale Roux, (unknown), Thérèse Gargi, Thomas Bachelot, Jean‐Paul Guastalla, (unknown), Christelle Fauré, David Pérol, Patrick Bachmann	64
9	Serum cytokines in follicular lymphoma. Correlation of TGF-β and VEGF with survival 2009 ·Annals of Hematology ·Sana Intidhar Labidi‐Galy, Christine Ménétrier‐Caux, Sylvie Chabaud, Catherine Chassagne, Catherine Sebban, Thérèse Gargi, Pierre Biron, Jean‐Yves Blay, Hervé Ghesquières	31
10	Combination of rituximab with chemotherapy in diffuse large B‐cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication 2008 ·Hematological Oncology ·Hervé Ghesquières, Céline Ferlay, Catherine Sebban, Catherine Chassagne, Liana Carausu, Thérèse Gargi, Bertrand Favier, Irène Philip, Jean‐Yves Blay, Pierre Biron	5
11	Time-to-event analysis with artificial neural networks: An integrated analytical and rule-based study for breast cancer 2008 ·Neural Networks ·Paulo Lisböa, Terence A. Etchells, Ian H. Jarman, Min Hane Aung, Sylvie Chabaud, Thomas Bachelot, David Pérol, Thérèse Gargi, Valérie Bourdès, Stéphane Bonnevay, Sylvie Négrier	14
12	Development of a Rule Based Prognostic Tool for HER 2 Positive Breast Cancer Patients 2007 ·Conference proceedings ·(unknown), Terence A. Etchells, Ian H. Jarman, Min Hane Aung, Sylvie Chabaud, Thomas Bachelot, David Pérol, Thérèse Gargi, (unknown), Stéphane Bonnevay, Sylvie Négrier	2
13	High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL) 2006 ·Leukemia ·Elias Jabbour, Serge Koscielny, Catherine Sebban, (unknown), Catherine Patte, Thérèse Gargi, Pierre Biron, Christophe Fermé, J. H. Bourhis, J Vantelon, P Arnaud, Vincent Ribrag	25
14	Second autologous transplantation after failure of a first autologous transplant in 18 patients with non-Hodgkin's lymphoma 2004 ·The Hematology Journal ·(unknown), Charles Dumontet, Thérèse Gargi, Catherine Chassagne, Françoise Berger, David Pérol, (unknown), Bertrand Coiffier, Jean‐Yves Blay	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact